Gapping down
In reaction to disappointing earnings/guidance:
- VFC -4.8%, PRA -4.2% (reports preliminary loss estimates; sees $37 mln of adverse development in Specialty Property & Casualty segment), RJF -4.2%, WBS -3.1%, FUL -2.8%, TCBI -2.6%, HBAN -1.9%, TRV -1.8%, PG -1.7%, TXN -1.1%, AAL -1%, CADE -0.9%, LUV -0.9%
Other news:
- KRTX -13.7% (still looking around for catalyst)
- AUTL -11.8% (prices offering of 7.25 mln ADSs at $11.00 per ADS)
- IMGN -7.3% (prices offering of 21.325 mln shares of common stock at $4.25 per share)
- ZYME -5.6% (announces pricing of $279.0 mln public offering)
- ACRE -3.6% (prices underwritten public offering of 4,000,000 shares of common stock for total estimated gross proceeds of approximately $64.4 mln)
- NK -3.6% (modestly pulling back from today's 15% move higher)
- MSON -2.9% (commences underwritten public offering of its common stock)
- XENE -2% (prices offering of 3.75 mln shares of common stock at $16.00 per share)
- MGY -1.2% (downgraded to Neutral at Credit Suisse)
Analyst comments:
- TSLA -1.8% (downgraded to Neutral from Outperform at Exane BNP Paribas)
- ALTR -1.4% (downgraded to Sell from Neutral at Guggenheim)
- W -1.2% (downgraded to Hold from Buy at Loop Capital)
- COP -1% (downgraded to Sector Perform from Sector Outperform at Scotiabank)
- DLTR -0.9% (downgraded to Neutral from Buy at BofA/Merrill)
- BJ -0.7% (downgraded to Neutral from Buy at BofA/Merrill)
- ORLY -0.7% (downgraded to Underweight from Neutral at Atlantic Equities)
- XOM -0.5% (downgraded to Sector Underperform from Sector Perform at Scotiabank)